Organon OGN
NYSE OGN
$13.64 -0.03 (-0.26%)
As of: Sep 10, 2026 · 3:59 PM EDT

Organon (OGN) EV to CFO (2021 - 2026)

Organon (OGN) posted EV to CFO of 22.65 for Q2 2026, up 1014.58% on a QoQ basis from 2.03 in Q1 2026, and up 159.89% year-over-year from 8.72 in Q2 2025.

Analysis

Organon (OGN) EV to CFO (2021 - 2026) Analysis & Trends

Organon has reported EV to CFO for 6 years, with the latest figure at 22.65 in Q2 2026.

  • On a quarterly basis, EV to CFO rose 159.89% year-over-year to 22.65 in Q2 2026; TTM through Jun 2026 was 3.29, a 41.67% increase from a year earlier, with the FY2025 full-year figure at 1.85, down 44.83% from the prior year.
  • EV to CFO was 22.65 for Q2 2026 at Organon, up from 2.03 in the prior quarter.
  • The five-year high for EV to CFO was 184.9 in Q2 2023, with the low at 2.03 in Q1 2026.
  • Average EV to CFO over 5 years is 34.38, with a median of 19.93 recorded in 2026.
  • The sharpest annual moves came in 2023 and 2026: EV to CFO jumped 247.34% in 2023, then tumbled 95.37% in 2026.
  • Over 5 years, EV to CFO stood at 23.96 in 2022, then tumbled by 68.63% to 7.52 in 2023, then advanced by 7.19% to 8.06 in 2024, then grew by 13.76% to 9.17 in 2025, then surged by 147.12% to 22.65 in 2026.
  • The last three EV to CFO figures came in at 22.65 (Q2 2026), 2.03 (Q1 2026), and 9.17 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 Organon 3.58 Bn 2.45 Bn 847.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.65
Mar 31, 2026 2.03
Dec 31, 2025 9.17
Sep 30, 2025 7.97
Jun 30, 2025 8.72
Mar 31, 2025 43.92
Dec 31, 2024 8.06
Sep 30, 2024 29.53
Jun 30, 2024 13.93
Mar 31, 2024 55.72
Dec 31, 2023 7.52
Sep 30, 2023 15.42
Jun 30, 2023 184.90
Mar 31, 2023 48.47
Dec 31, 2022 23.96
Sep 30, 2022 17.20
Jun 30, 2022 53.23
Mar 31, 2022 66.39
Dec 31, 2021 148.64
Sep 30, 2021 19.85